Sign In  |  Register  |  About San Rafael  |  Contact Us

San Rafael, CA
September 01, 2020 1:37pm
7-Day Forecast | Traffic

  • Search Hotels in San Rafael

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

118.60 +5.23 (+4.61%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
40 41 Next >
Could This Technology Hold The Potential To Help Prevent Alcohol-Related Accidents And Deaths?
Photo by Vinicius "amnx" Amano on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
Biden Says Baby Formula Shortage To Ease In Weeks With Increased Imports: Reuters
The U.S. is working with manufacturers to increase imports of baby formula, Biden told reporters. "We're going to be getting significantly more formula on shelves in a matter of weeks or less," he... 
Via Benzinga
Amid Baby Formula Shortage, Retailers Put Cap On Purchases: Report
Via Benzinga
Insider Weekends: "Adjusted" Insider Buying Increased Last Week With Insiders Purchasing $176.54 Million Of Stock
During a highly volatile week for markets, we saw insiders step up and purchase shares, although in aggregate it looked like both insider buying and selling declined compared to... 
Via Benzinga
Here's How Much $100 Invested In Abbott Laboratories 5 Years Ago Would Be Worth Today
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 8.78% on an annualized basis producing an average annual return of 20.13%. Currently, Abbott Laboratories has a... 
Via Benzinga
Expert Ratings for Abbott Laboratories
Abbott Laboratories (NYSE:ABT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Abbott Clocks Q1 COVID-19 Test Sales Of $3.3B, Reaffirms FY22 EPS Outlook
Via Benzinga
Peering Into Abbott Laboratories's Recent Short Interest
Abbott Laboratories's (NYSE:ABT) short percent of float has fallen 9.21% since its last report. The company recently reported that it has 12.10 million shares sold short, which is... 
Via Benzinga
Abbott Strengthens Its Connected Care Technologies With Latest Neurosphere™ Mypath™ Digital Health App
SOURCE: Abbott 
Via 3BL Media
How is it going with the Big Biopharma Earnings Week?
Abbott and JNJ kicked off healthcare earnings last week and the results were just OK. 
Via Talk Markets
EXCLUSIVE: Verano CIO Aaron Miles Says Company Is 'Strategically Building' As Crucial Markets Come Online
Verano Holdings Corp (OTC: VRNOF) CIO Aaron Miles tells Benzinga that he and the Chicago-based MSO have been able to grow in the often tumultuous cannabis market through market experience and strategic... 
Via Benzinga
3 Dividend Stocks for Value Investors Seeking Regular Income
The list includes high dividend paying stocks that are growing at a steady rate, suitable for income-seeking investors. 
Via InvestorPlace
Market Rally Hits Resistance; Netflix Crashes, Tesla, Lockheed, United Airlines, Alcoa In Focus: Weekly Review
The major indexes sold off after moving up to or above key levels. 
Via Investor's Business Daily
19 Dividend Stocks That Pay In February, May, August And November
Looking to fill in your dividend calendar? These top dividend stocks pay quarterly. 
Via Talk Markets
7 Stocks to Buy If You Think Inflation Is Topping Out
Some analysts believe that the market may have seen peak inflation. Here are seven stocks to buy if inflation is at or near its peak. 
Via InvestorPlace
What Does Raymond James, Wells Fargo Have To Say On Abbott's Q1 Earnings
Raymond James thinks Abbott Laboratories' (NYSE: ABT) 1Q results were solid and demonstrated the durable nature of ABT's portfolio, as three out of four business segments grew over 10% organically,... 
Via Benzinga
Homebuilders Hammer Away After Tuesday's Rally As Yields Tick Lower
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. (Wednesday Market Open) Equity index futures pointed to a... 
Via Benzinga
Abbott Labs First-Quarter Results Top Estimates, Earnings Outlook Short
ABT stock fell early Wednesday as it reported quarterly results that beat estimates, driven by $3.3 billion in sales of its COVID-19 tests. 
Via Investor's Business Daily
Benzinga's Daily Brief On Trending Tickers For April 20, 2022: Procter & Gamble, Lululemon, Netflix, And More
Benzinga’s “Daily Brief On Trending Tickers” features the top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks. 
Via Benzinga
Abbott Laboratories: Q1 Earnings Insights
Abbott Laboratories (NYSE:ABT) reported its Q1 earnings results on Wednesday, April 20, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
A Peek Into The Markets: US Stock Futures Flat Ahead Of Earnings; Netflix Shares Plunge
Pre-open movers 
Via Benzinga
5 Stocks To Watch For April 20, 2022
Some of the stocks that may grab investor focus today are: 
Via Benzinga
This Week's Earnings Spotlight: Tesla, Netflix, IBM, American Express, Snap And More
Here are the expected dates and insights into top companies' earnings reports, according to Benzinga Pro. Tuesday after-close: Spirit Airlines Inc (NYSE: SAVE) 
Via Benzinga
Earnings Scheduled For April 20, 2022
Companies Reporting Before The Bell • MarketAxess Holdings (NASDAQ:MKTX) is projected to report quarterly earnings at $1.68 per share on revenue of $186.63 million. 
Via Benzinga
If You Invested $1000 In Abbott Laboratories 5 Years Ago, Here's How Much You Would Have Today
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 8.67% on an annualized basis producing an average annual return of 21.94%. Currently, Abbott Laboratories has a... 
Via Benzinga
Earnings Preview: Abbott Laboratories
Abbott Laboratories (NYSE:ABT) is set to give its latest quarterly earnings report on Wednesday, 2022-04-20. Here's what investors need to know before the announcement. Analysts estimate that Abbott... 
Via Benzinga
Food Commodities Continue to Rise — Learn Who May Benefit
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
Biotech stocks retreated in the week ending April 14, lock-stepping with the broader market. The news flow was light during the holiday-shortened week and ahead of the imminent first-quarter reporting... 
Via Benzinga
Raymond James Thinks Med Tech Investors are Somewhat 'Paralyzed' Ahead Of Q1 Earnings
Via Benzinga
Looking Into Abbott Laboratories's Recent Short Interest
Abbott Laboratories's (NYSE:ABT) short percent of float has risen 28.81% since its last report. The company recently reported that it has 13.33 million shares sold short, which is... 
Via Benzinga
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
40 41 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanRafael.com & California Media Partners, LLC. All rights reserved.